Go to journal home page - The Lancet

Volume 392, Issue 10148

Pages 613-710, e7 (25–31 August 2018)

Actions for selected articles

/

Receive an update when the latest issues in this journal are published
Sign in to set up alerts
  1. The 2018 US midterm elections—health in the middle

    Page 613
  2. E-cigarettes—is the UK throwing caution to the wind?

    Page 614
  3. India's mega health reforms: treatment for half a billion

    Page 614
  4. Semaglutide and GLP-1 analogues as weight-loss agents

    Pages 615-616
  5. Risankizumab for psoriasis

    Pages 616-617
  6. Pain relief during labour: challenging the use of intramuscular pethidine

    Pages 617-619
  7. Addressing the global challenge of snake envenoming

    Pages 619-620
    View PDF
  8. The Lancet–EASL Commission on liver diseases in Europe: overcoming unmet needs, stigma, and inequities

    Pages 621-622
  9. DR Congo Ebola virus outbreak: responding in a conflict zone

    Page 623
    View PDF
  10. Experts fear a resurgence of leprosy in India

    Pages 624-625
  11. Hoarding disorder: a medical condition

    Page 626
  12. Now we're talking: bringing a voice to digital medicine

    Page 627
  13. David Whiteman: harnessing the power of cancer prevention

    Page 628
  14. From cradle to grave

    Page 629
  15. Arvid Carlsson

    Page 630
  16. Vitamin A distribution in danger: should we worry?

    Page 631
  17. Vitamin A distribution in danger: should we worry?

    Pages 631-632
  18. Did Cro-Magnon 1 have neurofibromatosis type 2?

    Pages 632-633
  19. Did Cro-Magnon 1 have neurofibromatosis type 2? – Authors' reply

    Page 633
  20. Subject of The Vaccine Race offers perspective on errors

    Pages 633-634
    View PDF
  21. Selected and non-selected non-communicable diseases

    Page 634
  22. On Hume and planetary health

    Pages 634-635
  23. MacArthur Foundation's investment in education: model for the future

    Pages 635-636
  24. The new face of China's foreign aid: where do we go from here?

    Page 636
  25. Department of Error

    Page 636
    View PDF
  26. Department of Error

    Page 636
    View PDF
  27. Department of Error

    Page 636
    View PDF
  28. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

    Pages 637-649
  29. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

    Pages 650-661
  30. Intravenous remifentanil patient-controlled analgesia versus intramuscular pethidine for pain relief in labour (RESPITE): an open-label, multicentre, randomised controlled trial

    Pages 662-672
    View PDF
  31. Vulnerability to snakebite envenoming: a global mapping of hotspots

    Pages 673-684
    View PDF
  32. Lipaemia retinalis in familial chylomicronaemia syndrome

    Page e7
  33. HIV

    Pages 685-697
  34. The global response and unmet actions for HIV and sex workers

    Pages 698-710

ISSN: 0140-6736